https://youtu.be/5mHuzRGWvRo
TORONTO, Jan. 8, 2020 /CNW/ - The View from
the C-Suite video interview series highlights the unique
perspectives of listed companies on Toronto Stock Exchange and TSX
Venture Exchange. Videos provide insight into how company
executives think in the current business environment. To see the
latest View from the C-Suite videos
visit www.tmxmoney.com/en/news/csuite.html)
About Theralase Technologies Inc. (TSXV: TLT)
Theralase® is a clinical stage pharmaceutical company dedicated
to the research and development of light activated Photo Dynamic
Compounds and their associated drug formulations intended to safely
and effectively destroy various cancers.
Additional information is available at www.theralase.com and
www.sedar.com
About TMX Group (TSX: X)
TMX Group's key subsidiaries operate cash and derivative markets
and clearinghouses for multiple asset classes including equities
and fixed income. Toronto Stock Exchange, TSX Venture Exchange, TSX
Alpha Exchange, The Canadian Depository for Securities, Montréal
Exchange, Canadian Derivatives Clearing Corporation,
Trayport and other TMX Group companies provide listing
markets, trading markets, clearing facilities, depository services,
technology solutions, data products and other services to the
global financial community. TMX Group is headquartered in
Toronto and operates offices
across North America (Montréal,
Calgary, Vancouver and New
York), as well as in key international markets including
London, Beijing and Singapore. For more information about TMX
Group, visit our website at www.tmx.com. Follow TMX Group on
Twitter: @TMXGroup.
SOURCE TMX Group Limited